Resolute zotarolimus stent approved in US TheHeart.Org The Resolute DES has shown similar safety and efficacy to the Xience V everolimus-eluting stent (Abbott), the market-leader in the US, in two randomized controlled trials (RESOLUTE "all-comers" and TWENTE). The results of TWENTE were presented at TCT ... |
